West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, that it will unveil its new Daikyo Crystal Zenith® 2.25m.
Insert Needle Syringe System at BIO International Convention, taking place in San Diego, CA from June 13-16, 2022.
Daikyo Crystal Zenith® (CZ®) is a technologically advanced cyclic olefin polymer containment and delivery system that offers an alternative to glass, mitigating the risk of breakage and reducing the chance of particulates, contamination, and extractables.
The 2.25mL CZ Insert Needle Syringe System is an expansion upon the 1mL Insert Needle Syringe System offering. Until now, the syringe system has only been available in sizes up to 1mL, but the new 2.25mL size allows for larger volume injections.
As market traction on larger dose injections grows, the new CZ syringe system size will help pharmaceutical companies to bring their product to patients in a safe and most user-centric model possible.
"By creating a larger fill volume in our high-quality CZ Insert Needle Syringe System, we're able to answer the needs of more patients with a safe and reliable containment solution," said Li Chen, VP and GM, Biologics at West.
"Where patients previously may have needed multiple injections to achieve their dose, the 2.25mL Insert Needle Syringe System will allow for fewer or less frequent injections enabling an easier patient experience."
West has partnered with Daikyo in an exclusive distributor arrangement to provide the CZ Insert Needle Syringe Systems syringe globally.
For more information, visit www.westpharma.com.
